申请人:——
公开号:US20030004164A1
公开(公告)日:2003-01-02
This invention describes novel pyrazole compounds of formula III:
1
wherein Z
1
, Z
2
, and Z
3
are as described in the specification; Q is —S—, —O—, —N(R
4
)—, or —CH(R
6
)—; R
1
is T-Ring D, wherein Ring D is a 5-7 membered monocyclic ring or 8-10 membered bicyclic ring selected from aryl, heteroaryl, heterocyclyl or carbocyclyl; and R
2
and R
2′
are as described in the specification. The compounds are useful as protein kinase inhibitors, especially as inhibitors of Aurora-2 and GSK-3, for treating diseases such as cancer, diabetes and Alzheimer's disease.
本发明描述了式 III 的新型吡唑化合物:
1
其中 Z
1
, Z
2
和 Z
3
如说明书所述;Q 是 -S-、-O-、-N(R
4
)-,或-CH(R
6
)-; R
1
是 T 环 D,其中环 D 是 5-7 个成员的单环或 8-10 个成员的双环,选自芳基、杂芳基、杂环或碳环;以及 R
2
和 R
2′
如说明书所述。这些化合物可用作蛋白激酶抑制剂,特别是 Aurora-2 和 GSK-3 的抑制剂,用于治疗癌症、糖尿病和阿尔茨海默病等疾病。